ARCHIVES

A Special Report: Language With A Purpose–von Eschenbach’s Four Years at NCI.

This article is from The Cancer Letter archive.

Vol. 32 No. 19 | May 19, 2006

Download PDF Visit The Full Archive

Related Articles

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

December 2, 2005

NCI Developing Plan To Replace Research Contracts At Academic Institutions With “Program Grants”

February 22, 1974

Agency Approves HPV Test That Detects 14 High-Risk Strains

November 25, 2011

Clearinghouse Group Selects 10 More Compounds To Test

January 13, 1978

Markup Completed On Senate Cancer Act Renewal; Waxman Agrees To $90 Million Centers Line Item

May 2, 1980